The review, led by Fang Li and Xiaoyu Liu of the Sichuan Cancer Hospital and Institute in Chengdu, China, together with colleagues across Sichuan and the China Medical University School of Nursing in Shenyang, took an unusually rigorous approach for a scoping review. Rather than simply cataloguing studies, the team mapped the entire landscape of digital symptom management interventions for patients in the peri-chemoradiotherapy period, meaning before, during and shortly after concurrent chemoradiation, and then interrogated that landscape through two established theoretical lenses: the United Kingdom Medical Research Council framework for complex interventions and the Capability-Opportunity-Motivation-Behaviour model of behaviour change.

The Medical Research Council framework matters because digital symptom management is not a simple drug or device. It is what researchers call a complex intervention, a bundle of interacting components, including symptom assessment tools, educational content, tailored feedback, remote monitoring and communication channels with clinicians, delivered through technology to patients whose physical condition and motivation fluctuate week by week. The framework forces developers to think systematically about how an intervention is built, how its mechanisms are supposed to work, how it will be implemented in real clinics and how it will be evaluated. The COM-B model complements this by asking whether patients truly have the capability, opportunity and motivation to use these tools consistently, which is precisely where many digital health projects quietly fail.

To assemble the evidence base, the researchers followed the Joanna Briggs Institute methodology and the PRISMA extension for scoping reviews, searching six major electronic databases, PubMed, Scopus, Embase, the Cochrane Library, Web of Science and CINAHL, along with grey literature sources, from inception to January 2026. The search captured 32 studies, a mix dominated by development and validation work rather than definitive trials. Most of the research came from high-income countries, a pattern the authors highlight as a signal of how unevenly this technology is being studied and deployed across the world, leaving patients in low- and middle-income settings largely outside the evidence base.

One of the review’s most useful contributions is its taxonomy of delivery. The digital interventions identified fell into seven distinct modalities, with dedicated programmes and websites and mobile applications emerging as the most common vehicles. The application scenarios the authors mapped are intuitive once spelled out: patients use these platforms to report symptoms in real time, receive education about what to expect from radiation to the head and neck, practise swallowing or mouth-care exercises, track nutritional intake, and in some cases trigger alerts to clinical teams when scores deteriorate. In principle, this closes a notorious gap in oncology care, where symptoms between hospital visits can escalate unnoticed until they become severe enough to require unplanned admissions or treatment interruptions.

The technical logic behind such tools is worth unpacking. Symptom tracking apps typically rely on validated patient-reported outcome measures, short questionnaires that patients complete on a phone or computer, converting subjective experience into quantifiable data streams. When those streams are monitored, clinicians can intervene earlier, adjusting pain medication, prescribing treatments for oral mucositis or arranging dietetic support before a patient becomes malnourished. Educational modules can be timed to the radiation schedule, delivering information about skin care or swallowing exercises precisely when they become relevant. Some platforms incorporate automated feedback, reminders and tailored coaching, which is where the COM-B model becomes directly operational: a reminder addresses motivation, a simplified interface addresses capability, and integration with hospital systems addresses opportunity.

Yet the review’s central finding is a sobering one, and it is captured in a phrase the authors use explicitly: the engagement-impact gap. Digital interventions in this field are frequently hindered by poorly sustained user engagement and insufficient clinical application. Patients download an app, use it enthusiastically for a week or two, and then drift away, often exactly when treatment side effects peak and energy for self-management collapses. Clinics pilot a platform and then struggle to embed it into routine workflows, funding structures and electronic health records. The result is a graveyard of well-intentioned prototypes that showed early promise but never achieved the sustained, integrated use required to change outcomes at scale.

By applying the Medical Research Council framework and the COM-B model to the collected evidence, the authors identified core implementation barriers and generated tentative, theory-informed proposals for optimising future interventions. These propositions, the team is careful to stress, are hypothesis-generating rather than proven; they lack direct validation from primary research. Still, the framework-based analysis gives the field something it has often lacked, a structured way to diagnose why a given intervention failed. Was the content too demanding for a fatigued patient with mouth pain, a capability problem? Did the app assume smartphone access or digital literacy the patient did not have, an opportunity problem? Did the feedback feel impersonal, eroding motivation? Each diagnosis points to a different fix.

What can clinicians and patients conclude today? The review’s verdict is that preliminary evidence indicates digital modalities may improve symptom control, but that most of the 32 included studies were limited by small sample sizes and non-controlled designs. In other words, the field is rich in prototypes and poor in proof. Without randomised, adequately powered, well-controlled trials, it remains impossible to say with confidence that any particular digital intervention improves swallowing outcomes, reduces hospital admissions or extends treatment completion rates compared with usual care. The authors are explicit that firm conclusions about effectiveness must wait for such trials, and their framework-based roadmap is intended to help designers build interventions robust enough to survive that testing.

The significance of this work extends beyond head and neck cancer. The peri-chemoradiotherapy period is arguably the hardest possible test case for digital symptom management, because it combines an intense, time-limited symptom trajectory with patients who are often exhausted, dehydrated and in pain. If engagement strategies can be engineered to work here, grounded in behaviour-change theory and developed through the staged, iterative process the Medical Research Council framework prescribes, the same principles should transfer to other cancer populations and chronic illnesses. For now, the message of the review is one of cautious optimism: the technology exists, the early signals are promising, and the next decade of work must shift from building apps to proving, with rigorous trials, that they genuinely lighten the burden borne by patients in the treatment chair.

Subject of Research: Digital health interventions for symptom management in head and neck cancer patients undergoing chemoradiotherapy

Article Title: Digital symptom management interventions for patients with head and neck cancer during peri-chemoradiotherapy: a scoping review using the UK Medical Research Council Framework

Article References: Li, F., Liu, X., Yin, L., Yang, Q., Zhang, H., Jiang, Q., Zhang, S., Wang, A., & Lyu, J. (2026). Digital symptom management interventions for patients with head and neck cancer during peri-chemoradiotherapy: a scoping review using the UK Medical Research Council Framework. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15667-9

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15667-9

Keywords: head and neck cancer, digital health interventions, symptom management, chemoradiotherapy, scoping review, Medical Research Council framework, COM-B model, patient-reported outcomes, mobile health, engagement-impact gap, oncology nursing, e-health

What makes sarcopenia during cancer treatment so difficult to prevent is that it is not a single problem with a single fix. Its development reflects interacting nutritional, inflammatory, metabolic, immune, behavioural, and functional disturbances, all unfolding against the backdrop of a demanding treatment schedule. In nasopharyngeal carcinoma, toxicities affecting oral intake, swallowing, and salivary function during radiotherapy compound these processes, driving progressive deterioration in nutritional status, physical activity, and daily functioning. Because risk and supportive care needs shift across the treatment trajectory, a preventive strategy that works in week one may be inadequate by week six. Yet current approaches remain fragmented, often delivered as isolated interventions targeting one aspect of care at a time. Nutritional supplementation, the most common strategy, plays an essential role in maintaining energy and protein intake, but interventions focused on nutrition alone may be insufficient to address the complex and evolving factors contributing to muscle loss during definitive treatment.

A research team led by Lijuan Xia of the General Hospital of Ningxia Medical University in China, working with colleagues including Naoko Hayashi of St. Luke’s International University in Tokyo, has now tackled this gap head-on. Writing in the journal Supportive Care in Cancer, they report the development of a context-sensitive supportive care pathway designed to coordinate multidisciplinary sarcopenia prevention across the entire nasopharyngeal carcinoma treatment trajectory. Crucially, the study does not claim to prove that the pathway works. Instead, its contribution lies in providing a transparent, theoretically informed account of how such a pathway should be built, drawing together evidence, theory, stakeholder perspectives, and real-world constraints before any effectiveness testing begins. The work was guided by the updated Medical Research Council framework for developing and evaluating complex interventions, a methodological blueprint that emphasises integrating multiple sources of knowledge through iterative refinement.

The development process was anchored by a multidisciplinary team of thirteen healthcare professionals: four physicians, four nurses, two dietitians, one physiotherapist, one clinical pharmacist, and one psychologist, each with at least fifteen years of professional experience and senior rank in their discipline. This team served as the core decision-making body, appraising candidate components, adapting them to local conditions, and finalising the operational structure across two formal face-to-face meetings held in February and March 2025. Foundational inputs came from five complementary activities: a systematic review of non-pharmacological interventions, semi-structured interviews with healthcare professionals, economic and resource considerations, programme theory development, and contextual analysis. The systematic review included 21 randomised controlled trials reported in 22 publications, all conducted in China, and revealed a strikingly uneven evidence base. Evidence was most extensive for nutritional interventions, while exercise and probiotic approaches were supported by fewer, more heterogeneous studies.

The qualitative component provided the implementation intelligence that evidence alone cannot supply. Of 26 healthcare professionals invited, 21 participated in interviews conducted between January and February 2025, spanning five physicians, seven nurses, three dietitians, two physiotherapists, two clinical pharmacists, and two psychologists. Reflexive thematic analysis, informed by the Theoretical Domains Framework as a sensitising lens, generated three overarching themes comprising eleven subthemes: knowledge and competency gaps, structural and implementation barriers, and key intervention suggestions. Participants described limited recognition of sarcopenia, unclear professional responsibilities, and fragmented multidisciplinary care. For pathway development, these findings were synthesised into four cross-cutting implementation requirements: recognition and professional competency, care organisation and multidisciplinary coordination, longitudinal monitoring and continuity of care, and patient self-management and family-supported care. Each requirement was mapped directly to a design response in the final pathway, creating an auditable link between what clinicians said was missing and what the pathway delivers.

Resource realities shaped several pragmatic decisions. Routine vitamin D supplementation was not adopted; it was restricted to patients with documented deficiency, following locally approved laboratory and clinical procedures. Probiotic support was retained as a context-adaptable rather than universally fixed component, because the formulations evaluated in nasopharyngeal carcinoma trials were not fully matched by locally available products, and similar products had limited routine affordability. Repeated specialised immunological testing was judged too resource-intensive for routine longitudinal care, so the team instead selected pragmatic supplementary monitoring measures derived from routinely collected clinical parameters, including the global immune-nutrition-inflammation index, the HALP score combining hemoglobin, albumin, lymphocyte, and platelet counts, and the prognostic nutritional index. These indices were not used as standalone diagnostic thresholds; their trends were interpreted alongside body weight, oral intake, symptoms, and treatment tolerance to inform reassessment and escalation decisions.

The final pathway rests on three interconnected structural elements. First, it specifies discipline-specific roles within a coordinated multidisciplinary workflow: physicians oversee clinical assessment and medical management, nurses conduct comprehensive assessment and education while coordinating communication, dietitians adjust individualised nutritional plans, physiotherapists assess function and guide safe activity, psychologists manage distress and support behavioural adaptation, and clinical pharmacists support symptom and medication management. Second, it defines six longitudinal care procedures: assessment and individualised planning, one-to-one education, weekly monitoring, multidisciplinary consultation for complex or escalating needs, scheduled multidisciplinary reassessment at key treatment time points, and an end-of-treatment review with a care summary. Third, it organises supportive care into five strategic domains: nutritional and immune management, exercise management, head and neck symptom cluster management, gastrointestinal symptom cluster management, and psycho-behavioural support.

Two operational features deserve particular attention. The pathway embeds a risk stratification system based on the 2019 Asian Working Group for Sarcopenia criteria, using bioelectrical impedance analysis to measure appendicular skeletal muscle mass index, handgrip strength, and six-metre gait speed. Low muscle mass with preserved strength and performance is treated as a pathway-level early-warning state, while body-weight losses of 2.5 percent and 5 percent from baseline serve as pragmatic triggers for early multidisciplinary review and further escalation of support respectively. The team is careful to note these thresholds are pathway triggers, not universally validated diagnostic cut-offs. Meanwhile, the psycho-behavioural domain is grounded in the theory of planned behaviour: education, goal setting, tailored feedback, and family reinforcement are designed to strengthen patients’ attitudes, perceived social norms, and sense of behavioural control, which in turn are hypothesised to improve adherence to nutritional, exercise, and symptom-management recommendations and ultimately preserve muscle mass, strength, and function.

Patient and family voices entered the process through informal consultations with six patients undergoing or recently completing definitive treatment and six family caregivers. Most participants were initially unfamiliar with the term sarcopenia and, after explanation by nursing staff, tended to relate it to the more familiar concept of malnutrition. Their feedback centred on practical needs, particularly nutritional support, physical activity, home-based self-management, and family involvement, and informed refinements to one-to-one education and caregiver engagement. The researchers are candid about limitations: the study did not evaluate feasibility or effectiveness, the evidence base for individual components was uneven, development was situated within the Chinese healthcare context, and patient involvement was consultative rather than a formal co-development partnership. A pilot randomised controlled trial protocol has since been published to operationalise the pathway for feasibility testing. The team’s central message stands: sarcopenia prevention during cancer treatment should be conceived not as a series of isolated interventions, but as a coordinated, longitudinal, multidisciplinary process, one that treats prevention as dynamic risk management rather than episodic repair.

Subject of Research: Development of a multidisciplinary supportive care pathway for sarcopenia prevention in patients with nasopharyngeal carcinoma undergoing definitive treatment

Article Title: Developing a supportive care pathway for sarcopenia prevention in nasopharyngeal carcinoma: a context-sensitive and implementation-oriented approach

Article References: Xia, L., Chen, S., Min, J., Ma, Z., Zhang, Y., Zhang, F., Liu, S., Yan, B., & Hayashi, N. (2026). Developing a supportive care pathway for sarcopenia prevention in nasopharyngeal carcinoma: a context-sensitive and implementation-oriented approach. Supportive Care in Cancer, 34(10), Article 1058. https://doi.org/10.1007/s00520-026-11242-4

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11242-4

Keywords: sarcopenia, nasopharyngeal carcinoma, supportive care, multidisciplinary care, cancer nutrition, exercise oncology, implementation science, Medical Research Council framework, chemoradiotherapy, patient self-management, symptom management, complex interventions

The research team, led by Michelle Veilleux of the Fondation Santé des Étudiants de France and Université Paris Cité, together with colleagues from INSERM research units and Paris hospitals, set out to build the program on firm methodological ground rather than on intuition. They followed the Medical Research Council framework for developing and evaluating complex interventions, a widely respected roadmap in health services research that insists on understanding the problem, identifying the underlying mechanisms of change, and tailoring the intervention to its implementation context before any evaluation takes place. This stepwise approach matters because training programs that skip the development phase frequently fail to change real-world behavior, no matter how well intentioned they are.

The first stage involved a rigorous assessment of learning needs. The team combined an analysis of the existing scientific literature with an examination of the patient context and semistructured interviews with professionals working in adolescent psychiatry. These interviews revealed a landscape of uncertainty: clinicians recognized that sexual health was relevant to their patients’ wellbeing but reported feeling ill equipped to discuss it, unsure of their role legitimacy, and concerned about the boundaries of professional practice. The needs assessment made clear that the barrier was not indifference but a genuine gap in knowledge, skills, and confidence, compounded by the sensitive and sometimes taboo nature of the subject.

From this groundwork, the researchers identified sixteen pedagogical objectives, which they organized into three coherent domains. The first domain covers sexual knowledge, including the physiological and pharmacological facts that clinicians need in order to understand how psychiatric disorders and psychotropic medications can affect desire, arousal, and sexual function in young patients. The second domain addresses professional attitudes and role legitimacy, tackling the internal and cultural barriers that make clinicians hesitant to see sexual health as part of their job. The third domain focuses on applied communication and intervention skills, translating knowledge and attitude into the practical ability to raise the topic, respond to disclosure, and intervene appropriately.

What distinguishes this intervention from many ad hoc training efforts is its explicit grounding in behavioral theory. The team constructed a theory of change model by combining social cognitive theory, the theory of reasoned action, and the World Health Organization’s guidelines for brief sexuality-related communication. Social cognitive theory emphasizes that behavior change depends on self-efficacy, the belief that one can successfully perform the behaviors in question, which can be built through modeling, guided practice, and mastery experiences. The theory of reasoned action adds that intentions to act are shaped by attitudes toward the behavior and by perceived social norms, meaning the training must also shift what clinicians believe is expected of them in their professional environment.

The WHO framework for brief sexuality-related communication supplies the clinical technique. It provides a structured, nonjudgmental way for health professionals to introduce sexual health into routine consultations, using open questions and permission-giving language that normalizes the topic without forcing disclosure. By weaving these three theoretical strands together, the intervention targets multiple determinants of behavior simultaneously: the capability to act, the confidence to act, and the motivation to act. This theory-driven architecture is the pedagogical core of the program and is intended to make the resulting behavior change durable rather than superficial.

The intervention itself takes the form of three training modules. The first is a short introductory session designed to open the subject, establish shared vocabulary, and signal institutional endorsement of the effort. The remaining two modules are skill-focused, using the theoretical models to build concrete competencies in recognizing the sexual health impacts of psychiatric disorders and psychotropic treatments, and in communicating about these issues with adolescents in a clinical setting. The modular structure allows the training to be adapted to different ward schedules and professional groups, from nurses and psychologists to psychiatrists, reflecting the multidisciplinary reality of adolescent psychiatric care.

Crucially, the developers did not design the program in a vacuum. They explored the specificities and needs of the implementation context, the actual adolescent psychiatry wards where the training would be deployed, and incorporated these findings into the design. This attention to context is a hallmark of the MRC framework and reflects a growing consensus in implementation science that an intervention’s success depends as much on fit with local workflows, hierarchies, and cultures as on the quality of its content. A training program that ignores the realities of a busy inpatient unit, for example, risks being perceived as an added burden rather than a valued resource.

The study was conducted as part of the SEX-T-ADO research project, registered as NCT05316948, and received a favorable opinion from a French Committee for the Protection of Persons, with data collection compliant with national regulations and the Declaration of Helsinki. The work was funded by a grant from the French program for research in nursing and paramedical sciences, known as PHRIP, and by the French National Association for Research and Technology, ANRT, underscoring the institutional commitment in France to strengthening the paramedical and nursing dimensions of this kind of care.

The authors are careful to frame this publication as a development study rather than a proof of effectiveness. A future evaluation is planned to assess whether the training actually changes professional behavior, knowledge, and attitudes, and to examine how the program is implemented across different clinical contexts. That evaluation will be the true test of the theory of change model. Still, the significance of the work lies in its demonstration that a sensitive, long-overlooked aspect of adolescent mental health care can be approached with the same scientific rigor as any other clinical intervention. For the many young psychiatric patients whose sexual wellbeing has been silently affected by their disorders and medications, and for the clinicians who have wanted to help but did not know how, this research offers a credible, evidence-based path forward.

Subject of Research: Development of a theory-based training intervention for psychiatry professionals on adolescent sexual health

Article Title: Development of a training intervention to support psychiatry professionnals in adressing sexual health with adolescents

Article References: Veilleux, M., Martin, P., Ghosn, J., Foussier, A., Thoison, C., Huas, C., Godart, N., & Bourmaud, A. (2026). Development of a training intervention to support psychiatry professionnals in adressing sexual health with adolescents. BMC Medical Education. https://doi.org/10.1186/s12909-026-10351-2

Image Credits: AI Generated

DOI: 10.1186/s12909-026-10351-2

Keywords: adolescent psychiatry, sexual health, medical education, training intervention, psychotropic medications, behavior change theory, Medical Research Council framework, clinical communication, mental health, intervention development, youth mental health, health professionals